Institutional & Family Asset Management LLC raised its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 19,346 shares of the healthcare conglomerate’s stock after buying an additional 857 shares during the quarter. Institutional & Family Asset Management LLC’s holdings in UnitedHealth Group were worth $3,789,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Marshall Wace LLP grew its holdings in shares of UnitedHealth Group by 441.4% during the second quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after purchasing an additional 11,361 shares in the last quarter. American Century Companies Inc. grew its holdings in shares of UnitedHealth Group by 16.9% during the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after purchasing an additional 681,111 shares in the last quarter. DekaBank Deutsche Girozentrale grew its holdings in shares of UnitedHealth Group by 2.0% during the third quarter. DekaBank Deutsche Girozentrale now owns 489,647 shares of the healthcare conglomerate’s stock worth $95,646,000 after purchasing an additional 9,810 shares in the last quarter. Essex Financial Services Inc. grew its holdings in shares of UnitedHealth Group by 12.3% during the second quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after purchasing an additional 967 shares in the last quarter. Finally, Bainco International Investors grew its holdings in shares of UnitedHealth Group by 5.4% during the third quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock worth $16,192,000 after purchasing an additional 4,202 shares in the last quarter. 86.24% of the stock is owned by institutional investors and hedge funds.

Shares of UnitedHealth Group Inc (NYSE UNH) opened at $220.96 on Monday. The firm has a market capitalization of $214,130.00, a P/E ratio of 20.63, a P/E/G ratio of 1.29 and a beta of 0.70. UnitedHealth Group Inc has a 12-month low of $156.49 and a 12-month high of $250.79. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. The company had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. UnitedHealth Group’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.11 EPS. analysts expect that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.

In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the sale, the chief executive officer now owns 195,314 shares in the company, valued at $43,310,879.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kenneth Irwin Shine sold 198 shares of the business’s stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $242.55, for a total value of $48,024.90. Following the completion of the sale, the director now owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The disclosure for this sale can be found here. Insiders sold 53,853 shares of company stock valued at $12,358,508 in the last quarter. Corporate insiders own 0.89% of the company’s stock.

Several research analysts have recently commented on UNH shares. Cantor Fitzgerald reissued a “buy” rating and set a $225.00 price objective on shares of UnitedHealth Group in a report on Monday, November 27th. Piper Jaffray Companies boosted their price objective on UnitedHealth Group to $228.00 and gave the stock an “overweight” rating in a report on Tuesday, October 17th. Jefferies Group reissued a “buy” rating and set a $248.00 price objective on shares of UnitedHealth Group in a report on Friday, December 1st. Deutsche Bank boosted their price objective on UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Finally, Credit Suisse Group started coverage on UnitedHealth Group in a report on Thursday, November 2nd. They set an “outperform” rating and a $233.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. UnitedHealth Group currently has an average rating of “Buy” and an average target price of $243.22.

ILLEGAL ACTIVITY NOTICE: This article was published by Daily Political and is the property of of Daily Political. If you are reading this article on another website, it was illegally stolen and republished in violation of international copyright and trademark laws. The legal version of this article can be read at https://www.dailypolitical.com/2018/02/12/unitedhealth-group-inc-unh-holdings-lifted-by-institutional-family-asset-management-llc.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.